The LDL Receptor-Related Protein 1 (LRP1) Regulates the PDGF Signaling Pathway by Binding the Protein Phosphatase SHP-2 and Modulating SHP-2- Mediated PDGF Signaling Events

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Craig, Julie ^a   Mikhailenko, Irina ^a,b   Noyes, Nathaniel ^a   Migliorini, Mary ^a,b   Strickland, Dudley K ^a,b  

^a Center for Vascular and Inflammatory Diseases   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNASORE; ENZYME INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CELL COMPARTMENTALIZATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NEWBORN; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; ENDOSOMES; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN INTERACTION MAPS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 84880804841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070432     Document Type: Article

References (45)

1. Sharma S, Christopoulos C, Kukreja N, Gorog DA, (2011) Local drug delivery for percutaneous coronary intervention. Pharmacol Ther 129: 260-266 S0163-7258(10)00218-4 [pii];10.1016/j.pharmthera.2010.11.003 [doi].
2. Newby AC, Zaltsman AB, (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309.
3. Pompili VJ, Gordon D, San H, Yang Z, Muller DWM, et al. (1995) Expression and Function of a Recombinant PDGF B Gene in Porcine Arteries. Arterioscler Thromb Vasc Biol 15: 2254-2264.
4. Lindahl P, Johansson BR, Leveen P, Betsholtz C, (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
5. Betsholtz C, Lindblom P, Bjarnegard M, Enge M, Gerhardt H, et al. (2004) Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr Opin Nephrol Hypertens 13: 45-52.
6. Abe Ji, Deguchi J, Matsumoto T, Takuwa N, Noda M, et al. (1997) Stimulated Activation of Platelet-Derived Growth Factor Receptor In Vivo in Balloon-Injured Arteries: A Link Between Angiotensin II and Intimal Thickening. Circulation 96: 1906-1913.
7. Panek RL, Dahring TK, Olszewski BJ, Keiser JA, (1997) PDGF Receptor Protein Tyrosine Kinase Expression in the Balloon-Injured Rat Carotid Artery. Arterioscler Thromb Vasc Biol 17: 1283-1288.
8. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, et al. (1991) Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253: 1129-1132.
9. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW, (1992) Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89: 507-511.
10. Nabel EG, Yang Z, Liptay S, San H, Gordon D, et al. (1993) Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest 91: 1822-1829.
11. Herz J, Strickland DK, (2001) LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784.
12. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK, (2008) LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies. Physiol Rev 88: 887-918.
13. Boucher P, Gotthardt M, Li WP, Anderson RGW, Herz J, (2003) LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis. Science 300: 329.
14. George D, (2003) Targeting PDGF receptors in cancer-rationales and proof of concept clinical trials. Adv Exp Med Biol 532: 141-151.
15. Newton CS, Loukinova E, Mikhailenko I, Ranganathan S, Gao Y, et al. (2005) Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J Biol Chem 280: 27872-27878.
16. Loukinova E, Ranganathan S, Kuznetsov S, Gorlatov N, Migliorini MM, et al. (2002) PDGF-induced tyrosine phosphorylation of the LDL receptor-related protein (LRP): Evidence for integrated co-receptor function between LRP and the PDGF receptor. J Biol Chem 277: 15499-15506.
17. Muratoglu SC, Mikhailenko I, Newton C, Migliorini M, Strickland DK, (2010) Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway. J Biol Chem 285: 14308-14317.
18. Barnes H, Larsen B, Tyers M, van Der GP, (2001) Tyrosine phosphorylated LDL receptor-related protein 1 (LRP1) associates with the adaptor protein Shc in Src-transformed cells. J Biol Chem 22: 19119-19125.
19. Guttman M, Betts GN, Barnes H, Ghassemian M, van der Geer P, et al. (2009) Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics 9: 5016-5028 10.1002/pmic.200900457 [doi].
20. Betts GN, van der Geer P, Komives EA, (2008) Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain. J Biol Chem 283: 15656-15664 M709514200 [pii];10.1074/jbc.M709514200 [doi].
21. Freeman RM Jr, Plutzky J, Neel BG, (1992) Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci U S A 89: 11239-11243.
22. Kazlauskas A, Feng GS, Pawson T, Valius M, (1993) The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc Natl Acad Sci U S A 90: 6939-6943.
23. Ronnstrand L, Arvidsson AK, Kallin A, Rorsman C, Hellman U, et al. (1999) SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis. Oncogene 18: 3696-3702 10.1038/sj.onc.1202705 [doi].
24. Salicioni AM, Mizelle KS, Loukinova E, Mikhailenko I, Strickland DK, et al. (2002) The low density lipoprotein receptor-related protein mediates fibronectin catabolism and inhibits fibronectin accumulation on cell surfaces. J Biol Chem 277: 16160-16166.
25. Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorini M, et al. (1990) Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265: 17401-17404.
26. Chen L, Sung SS, Yip ML, Lawrence HR, Ren Y, et al. (2006) Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 70: 562-570.
27. Ranganathan S, Liu CX, Migliorini MM, Von Arnim CA, Peltan IDet al. (2004) Serine and threonine phosphorylation of the LDL receptor-related protein (LRP) by protein kinase Calpha regulates endocytosis and association with adaptor molecules. J Biol Chem.
28. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850 S1534-5807(06)00163-8 [pii];10.1016/j.devcel.2006.04.002 [doi].
29. Barnes H, Ackermann EJ, van Der GP, (2003) v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1. Oncogene 22: 3589-3597.
30. Boucher P, Liu P, Gotthardt M, Hiesberger T, Anderson RG, et al. (2002) Platelet-derived Growth Factor Mediates Tyrosine Phosphorylation of the Cytoplasmic Domain of the Low Density Lipoprotein Receptor-related Protein in Caveolae. J Biol Chem 277: 15507-15513.
31. Klinghoffer RA, Kazlauskas A, (1995) Identification of a putative Syp substrate, the PDGF beta receptor. J Biol Chem 270: 22208-22217.
32. Louis SF, Zahradka P, (2010) Vascular smooth muscle cell motility: From migration to invasion. Exp Clin Cardiol 15: e75-e85.
33. Owens GK, Kumar MS, Wamhoff BR, (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
34. Boucher P, Li WP, Matz RL, Takayama Y, Auwerx J, et al. (2007) LRP1 Functions as an Atheroprotective Integrator of TGFbeta and PDFG Signals in the Vascular Wall: Implications for Marfan Syndrome. PLoS ONE 2: e448.
35. Zhou L, Takayama Y, Boucher P, Tallquist MD, Herz J, (2009) LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PloS One 4: e6922.
36. Basford JE, Moore ZW, Zhou L, Herz J, Hui DY, (2009) Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation. Arterioscler Thromb Vasc Biol 29: 1772-1778.
37. Takayama Y, May P, Anderson RG, Herz J, (2005) Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Controls Endocytosis and c-CBL-mediated Ubiquitination of the Platelet-derived Growth Factor Receptor {beta} (PDGFR{beta}). J Biol Chem 280: 18504-18510.
38. Lu X, Qu CK, Shi ZQ, Feng GS, (1998) Downregulation of platelet-derived growth factor receptor-beta in Shp-2 mutant fibroblast cell lines. Oncogene 17: 441-448 10.1038/sj.onc.1201988 [doi].
39. Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, et al. (2001) The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20: 6018-6025 10.1038/sj.onc.1204699 [doi].
40. Qi JH, Ito N, Claesson-Welsh L, (1999) Tyrosine phosphatase SHP-2 is involved in regulation of platelet-derived growth factor-induced migration. J Biol Chem 274: 14455-14463.
41. Adachi M, Iwaki H, Shindoh M, Akao Y, Hachiya T, et al. (1997) Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells. Virchows Arch 430: 321-325.
42. Chang Y, Zhuang D, Zhang C, Hassid A, (2004) Increase of PTP levels in vascular injury and in cultured aortic smooth muscle cells treated with specific growth factors. Am J Physiol Heart Circ Physiol 287: H2201-H2208 10.1152/ajpheart.00520.2004 [doi];00520.2004 [pii].
43. Micke P, Hackbusch D, Mercan S, Stawowy P, Tsuprykov O, et al. (2009) Regulation of tyrosine phosphatases in the adventitia during vascular remodelling. Biochem Biophys Res Commun 382: 678-684 S0006-291X(09)00544-0 [pii];10.1016/j.bbrc.2009.03.078 [doi].
44. Won KJ, Lee HM, Lee CK, Lin HY, Na H, et al. (2011) Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway. J Pharmacol Sci 115: 164-175.
45. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, et al. (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143: 1136-1148 S0092-8674(10)01356-5 [pii];10.1016/j.cell.2010.11.034 [doi].